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Background: Smoking has been linked to low-grade systemic inflammation, a known risk factor for disease. This
state is reflected in elevated white blood cell (WBC) count.
Objective: We analyzed the relationship between WBC count and smoking in healthy men and women across
several age ranges who underwent preventive medical check-ups in the workplace. We also analysed the
relationship between smoking and lung function.
Methods: Cross-sectional descriptive study in 163 459 men and 59 382 women aged between 16 and 70 years.
Data analysed were smoking status, WBC count, and spirometry readings.
Results: Total WBC showed higher counts in both male and female smokers, around 1000 to 1300 cell/ml (t test,
P< 0.001). Forced expiratory volume in 1 second (FEV1%) was higher in nonsmokers for both sexes between 25 to
54 years (t test, P< 0.001). Analysis of covariance showed a multiple variable effect of age, sex, smoking status, body
mass index on WBC count. The relationship between WBC blood count and smoking status was confirmed after
the sample was stratified for these variables. Smokers with airway obstruction measured by FEV1% were found to
have higher WBC counts, in comparison to smokers with a normal FEV1% among similar age and BMI groups.
Conclusions: Smoking increases WBC count and affects lung function. The effects are evident across a wide age
range, underlining the importance of initiating preventive measures as soon as an individual begins to smoke.Background
Since the 1970s smoking has been linked to low-grade
systemic inflammation as reflected in elevated white
blood cell (WBC) count [1-3], a well-established pre-
dictor of such serious health events as myocardial infarc-
tion [4], cancer [5], and chronic obstructive pulmonary
disease [6]. Experiments in animals have demonstrated
that tobacco smoke promotes leukocyte transit from
bone marrow to small pulmonary vessels and that the ef-
fect on alveolar walls favours the development of pul-
monary emphysema [7]. However, WBC count is also
influenced by a range of acute and chronic infectious
and inflammatory processes that are difficult to screen* Correspondence: jafiz@msn.com
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reproduction in any medium, provided the orfor in population studies [8,9]. We therefore sought to
describe the behaviour of WBC count in subjects known
to be free of health conditions that could affect the
results of laboratory tests, in the interest of providing
data that would be useful for comparison with studies of
the effect of tobacco smoking in either healthy or dis-
eased populations.
To that end we analysed data available for a healthy
employed population of men and women in a wide age
range. Health vigilance programmes in Spain require
that individuals undergoing preventive medical check-
ups in the workplace be free of any acute condition.
When a worker is found to have an acute illness or an
exacerbation of a chronic condition, the examination is
postponed until the person has recovered. Therefore, the
worker is known to be healthy at the time blood samples
are taken. Our hypothesis was that laboratory results forThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Anthropometric values of the population of healthy workers
Male Female
Nonsmokers Smokers All Nonsmokers Smokers All
(n = 78 306) (n = 85 153) (n = 163 459 (n= 27 883) (n = 31 499) (n =59 382)
Age (years) 41.7 (41.59–41.74) 38.29 (38.22–38.36)* 39.91 (39.85–39.96) 40.84 (40.71–40.96) 36.70 (36.60–36.80)* 38.64 (38.56–38.73)
Weight (kg) 82.6 (82.48–82.67) 80.94 (80.95–81.04)* 81.78 (81.66–81.79) 64.71 (64.57–64.85) 63.41 (63.28–63.54)* 64.02 (63.92–64.12)
Height (m) 1.735 (1.735–1.736) 1.742 (1.741–1.742) 1.739 (1.738–1.739) 1.613 (1.612–1.614) 1.625 (1.624–1.625)* 1.619 (1.618–1.620)
BMI (kg/m2) 27.4 (27.36–27.41) 26.65 (26.62–26.68)* 27.00 (26.98–27.02) 24.89 (24.84–24.95) 24.02 (23.97–24.07) 24.43 (24.39–24.47)
Values are means and 95% confidence intervals.
* Statistically significant differences between smokers and nonsmokers (t test for independent groups, P< 0.05).
BMI Body Mass Index.
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by nonsmoking-related factors that might affect WBC
count in a random population-based sample.
To confirm that smoking by itself leads to a state of sus-
tained systemic inflammation, we conducted a cross-
sectional study of WBC count in healthy male and female
smokers and nonsmokers across several age ranges who
underwent preventive medical check-ups in the workplace,
analysing the relationship between smoking and WBC
count. Additionally, we sought to confirm a relationship
between WBC count and declining lung function.
Material and methods
Design and setting
For this cross-sectional descriptive study we gathered
clinical data from the 2009 records of Ibermutuamur So-
ciety for Preventive Medicine (Sociedad de Prevención
de Ibermutuamur, Madrid). In 2009, this occupational
health insurer covered 518 587 workers in 29 845 com-
panies located throughout Spain. A total of 380 353 indi-
viduals underwent a regularly scheduled health check-up
as part of the insurer’s vigilance programme.
Study population
Data for 163 459 men and 59 382 women, all white, be-
tween the ages of 16 and 70 years were examined between
1 January and 31 December 2009. This population sample,Table 2 BMI for healthy workers
Male
Age (years) Nonsmokers Smokers
(n = 78 306) (n = 85 153)
16–24 24.85 (24.73–24.97)* 24.23 (24.14–2
25–34 26.30 (26.24–26.35)* 26.02 (25.97–2
35–44 27.43 (27.38–27.48)* 27.11 (27.06–2
45–54 28.21 (28.16–28.26)* 27.53 (27.47–2
55–64 28.55 (28.48–28.62)* 27.68 (27.58–2
>64 28.23 (27.83–28.62) 27.72 (27.02–2
Values are means and 95% confidence intervals.
* Statistically significant differences between smokers and nonsmokers, for both ma
BMI: Body Mass Index (kg/m2). n: Subjects number.accounting for 58.6% of the insured workers attending the
preventive medical check-up that year, met all the require-
ments for inclusion. Thus, morning blood samples were
taken from workers who had fasted for at least 12 hours
and who had been told not to smoke before the check-up.
Subjects were allowed to have taken any prescribed medi-
cations with water.
Data collection and variables
An exhaustive medical history included the variables of
interest for this study: smoking status (current smoker or
nonsmoker), WBC count in peripheral blood (cells/ml),
and spirometry readings (forced vital capacity [FVC],
forced expiratory volume in 1 second [FEV1], and the ratio
of FEV1 to FVC). The data belong to the health vigilance
programme of the insurer, which is responsible for safe
storage.
Other variables on record were anthropometric
data (weight, height, body mass index [BMI] calcu-
lated as kg/m2). To calculate BMI weight and height
were measured (SECA-711 220, Class III scale; Med-
izinische Waagen und Messsysteme, Hamburg, Ger-
many) with the worker wearing light clothing and no
shoes. To reduce clothing weight further, objects
were removed from pockets and belts and other ac-
cessories were taken off. These measurements were
taken in the morning after urination and fasting.Female
Nonsmokers Smokers
(n = 27 883) (n =31 499)
4.33) 22.99 (22.79–23.20) 22.86 (22.70–23.02)
6.07) 23.54 (23.45–23.64) 23.34 (23.26–23.41)
7.16) 24.71 (24.61–24.81)* 24.21 (24.13–24.30)
7.60) 25.89(25.79–25.99)* 25.23 (25.12–25.34)
7.78) 26.90 (26.74–27.05)* 25.83 (25.59–26.03)
8.42) 26.78 (26.08–27.49) 24.69 (21.44–27.93)
les and females (t test for independent groups, P< 0.001).




Nonsmokers Smokers All Nonsmokers Smokers All
(n = 78 306) (n = 85 153) (n = 163 459) (n = 27 883) (n = 31 499) (n = 59 382)
16–24 6555 (6509–6601)* 7296 (7253–7339) 7010 (6978–7042)1 6771 (6681–6861)* 7391 (7317–7466) 7168 (7109–7226)
25–34 6456 (6434–6437)* 7569 (7546–7592) 7118 (7100–7135) 6523 (6485–6561)* 7292 (7257–7327) 6995 (6968–7021)
35–44 6436 (6416–6455)* 7927 (7902–7953) 7244 (7226–7261) 6368 (6333–6404)* 7441 (7401–7480) 6973 (6944–7001)
45–54 6512 (6491–6532)* 8124 (8092–8155) 7245 (7225–7265) 6164 (6132–6196)* 7421 (7372–7471) 6699 (6670–6729)
55–64 6600 (6572–6629)* 7914 (7864–7965) 7076 (7048–7103) 5989 (5939–6040)* 7235 (7126–7343) 6313 (6264–6363)
>64 6518 (6358–6680) 7410 (7132–7688) 6744 (6600–6888) 5987 (5677–6296) 6821 (5489–8153) 6058 (5758–6359)
Values are means and 95% confidence intervals.
* Statistically significant differences between smokers and nonsmokers, for both males and females (t test for independent groups, P< 0.001).
n: Subject number.
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independent company (Reimedical, SL; Madrid, Spain).
For spirometry, examiners used a Spirolab II RS232 de-
vice (Medical International Research, Rome, Italy) as part
of the routine check-up. To ensure quality of measure-
ments, the equipment was inspected by the health insurer’s
staff and calibrated by an independent company, followingFigure 1 White blood cell count in a) male smokers and b) male
nonsmokers.the guidelines of the Spanish Society of Pulmonology and
Thoracic Surgery (SEPAR) [10]. The worker was encour-
aged by the examiner to take a deep breath and then ex-
hale as forcefully as possible. The highest values for FVC
and FEV1 were recorded. The results were compared with
reference values for a Spanish population, using the most
recently updated tables [11].Figure 2 White blood cell count in a) female smokers and
b) female nonsmokers.
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tory (Megalab, SA, Madrid) using the same automated
cell counter (Cell-Dyn Sapphire, Abbott Laboratories,
Abbott Park, IL, USA).
Statistical analysis
After verifying normality of distribution, we subjected
the data set to t test analysis or variance analysis
(ANOVA) to compare differences between groups, fol-
lowed by analysis of covariance (ANCOVA) to find con-
founding variables. Medians were compared using
nonparametric tests as appropriate for the variable. Smo-
kers and nonsmokers were compared by sex and by age
and BMI strata. Results of ANOVA were expressed as
mean (SD) and 95% confidence interval (CI); results of
ANCOVA were expressed as mean (SEM). P values less
than 0.05 were considered statistically significant. Statis-
tics were compiled and analysed with GraphPad Quick
Calcs software (San Diego, CA, USA).
Results
The characteristics of the population of 163 459 men and
59 382 women are shown in Table 1, by smoking habit.





(n=78 306) (n=85 153)
16–24
FEV1 (l) 4.245 (4.225–4.265) 4.219 (4.203–4.23
FEV1% 98.5 (98.1–98.9) 98.3 (98.0–98.6)
25–34
FEV1 (l) 4.170 (4.160–4.1807) 4.140 (4.132–4.14
FEV1% 100.4 (100.2–100.6)* 99.3 (99.1–99.5)
35–44
FEV1 (l) 3.936 (3.928–3.945) 3.832 (3.824–3.83
FEV1% 102.3 (102.1–102.5)* 99.4 (99.2–99.6)
45–54
FEV1 (l) 3.588 (3.580–3.596) 3.388 (3.379–3.39
FEV1% 102.6 (102.3–102.8)* 97.0 (96.7–97.2)
55–64
FEV1 (l) 3.142 (3.131–3.153)* 2.917 (2.901–2.93
FEV1% 100.8 (100.4–101.1) 93.5 (93.0–93.9)
>64
FEV1 (l) 2.887 (2.825–2.949) 2.576 (2.475–2.67
FEV1% 98.9 (97.7–100.8)* 90.3 (86.8–93.7)
Values are means and 95% confidence intervals.
* Statistically significant differences in FEV1% between smokers and nonsmokers fo
FEV1(l): Forced expiratory volume in 1 second in liters.
FEV1%: Forced expiratory volume in one second in percentage respect to normal valuedifferences between smokers and nosmokers (P< 0.05).
Among males the BMI of non smokers was statistically
higher than that of smokers (by less than 1 kg/m3)
among all age groups, while among females, BMI was
statistically higher among non smokers (by less than
1 kg/m3) (Table 2).
Total WBC counts were higher in smokers of both
sexes by around 1180 cells/ml (ANOVA, P< 0.001; t test
for independent data, P< 0.001). ANOVA confirmed age
(in six ranges) and smoking (in two categories) as inde-
pendently associated with WBC count in men and women
(Table 3). Men have around 1000 cells/ml more than
women. Scatterplots of the point distribution of WBC
counts for the population show that higher counts were
found in male and female smokers (Figures 1 and 2).
The analysis of spirometric findings by smoking status,
age and sex showed that FEV1% (Forced expiratory vol-
ume in one second in percentage respect to normal
values) was higher in male nonsmokers from the age of
25 years onward and in female nonsmokers in the range
of ages from 25 years to 54 years (Table 4). The findings
were similar for the FEV1/FVC ratio and FVC% (Forced
vital capacity expressed as a percentage respect to nor-
mal values) (Table 5).1%) in active workers
Female
Nonsmokers Smokers
(n=27 883) (n=31 499)
4) 3.075 (3.050–3.100) 3.083 (3.065–3.101)
94.3 (93.6–94.9) 94.6 (94.1–95.1)
8) 3.073 (3.063–3.084) 3.067 (3.060–3.075)
98.6 (98.3–98.9)* 97.8 (97.5–97.9)
9) 2.918 (2.908–2.929) 2.861 (2.851–2.870)
102.6 (102.2–102.9)* 100.1 (99.8–100.4)
7) 2.630 (2.620–2.639) 2.536 ( 2.525–2.548)
103.9 (103.5–104.2)* 98.7 (98.3–99.1)
2) 2.305 (2.290–2.320) 2.219 (2.186–2.239)
103.6 (103.0–104.2) 98.6 (97.5–99.8)
7) 2.051 (1.955–2.14) 1.851 (1.538–2.163)
104.5 (99.9–109) 86.5 (79.1–93.9)
r males and females (t test for independent groups, P< 0.001).
s.
Table 5 Forced vital capacity (FVC) and FVC% and the ratio FEV1 to FVC (FEV1/FVC%) in healthy active workers
Males Females
Age (years) Nonsmokers (n=78 306) Smokers (n=85 153) Nonsmokers (n=27 883) Smokers (n=31 499)
16–24
FEV1/FVC% 86.9(86.7–87.2)* 86.2 (86.0–86.4) 88.0 (87.6–88.5)* 86.9 (86.7–87.3)
FVC (l) 4.907 (4.885–4.930) 4.920 (4.902–4.937) 3.520 (3.481–3.538) 3.560 (3.539–3.581)
FVC% 96.0 (95.6–96.4)* 96.9 (96.6–97.3) 93.4 (92.7–94.0) 94.8 (94.3–95.3)
25–34
FEV1/FVC% 86.0 (85.9–86.1)* 85.3 (85.2–85.4) 87.2 (87.1–87.4)* 86.4 (86.3–86.6)
FVC (l) 4.873 (4.864–4.884) 4.875 (4.865–4.883) 3.540 (3.527–3.553) 3.563 (3.553–3.573)
FVC% 97.4 (97.7–98.0) 97.7 (97.6–97.9) 98.1 (97.8–98.4 98.3 (98.0–98.5)
35–44
FEV1/FVC% 85.6 (85.5–85.7)* 84.5 (84.4–84.6) 86.3 (86.1–86.5)* 85.1 (84.9–85.2)
FVC (l) 4.623 (4.613–4.633) 4.556 (4.547–4.565) 3.399 (3.386–3.412) 3.378 (3.367–3.389)
FVC% 98.8 (98.7–99.0)* 97.4 (97.2–97.6) 102.2 (101.8–102.5) 101.4 (101.1–101.7)
45–54
FEV1/FVC% 85.3 (85.2–85.4)* 83.2 (83.1–83.3) 85.9 (85.8–86.1)* 83.9 (83.7–84.1)
FVC( l) 4.224 (4.214–4.233) 4.088 (4.077–4.099) 3.075 (3.063–3.087) 3.036 (3.022–3.049)
FVC% 97.7 (97.5–97.9)* 94.9 (94.7–95.1) 102.8 (102.5–103.2)* 100.2 (99.7–100.6)
55–64
FEV1/FVC% 84.2 (84.1–84.4)* 81.6 (81.3–81.8) 85.5 (85.2–85.8)* 83.7 (83.2–84.2)
FVC (l) 3.746 (3.733–3.759) 3.588 (3.570–3.605) 2.710 (2.692–2.729) 2.654 (2.623–2.685)
FVC% 95.6 (95.3–95.9)* 91.6 (91.2–92.0) 101.8 (101.2–102.5)* 98.9 (97.8–100.0)
>64
FEV1/FVC% 83.4 (82.5–84.3)* 80.2 (78.3–82.2) 85.8 (84.0–87.6) 79.4 (71.8–86.9)
FVC (l) 3.230 (3.112–3.350) 3.480 (3.405–3.554) 2.396 (2.293–2.499) 2.350 (1.955–2.744)
FVC% 88.9 (85.6–92.2) 92.9 (91.2–94.6) 101.2 (97.2–105.1) 86.7 (79.9–93.6)
Values are means and 95% confidence intervals.
* Statistically significant differences between smokers and nonsmokers for males and females (t test for independent groups, with P< 0.001).
FVC(l):Forced vital capacity in liters.
FVC(%):Forced vital capacity expressed as a percentage respect to normal values..
FEV1: Forced volume in 1 second in liters.
FEV1/FVC%: The ratio of FEV1 to FVC expressed as a percentage.
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FEV1% was compared between age ranges, sexes, BMI
ranges, and WBC count, we detected significant differ-
ences for male smokers between the ages of 35 and
64 years, regardless of BMI, and for female smokers with a
BMI <30 between the ages of 44 and 54 years (Table 6).
ANCOVA confirmed the effect of age, sex, smoking and
BMI on log (WBC) count demonstrating that the weight
of the variable smoking was greater than all the other vari-
ables. In the established model for the logarithm of WBC
count were included the set of covariates given by smok-
ing, sex, BMI and age. All variables were statistically sig-
nificant. About smoking, smokers have statistically higher
levels of WBC than not smokers (estimated coeff = 0.176,
SE= 0.001). Abou sex, males have statistically higher levels
of WBC than females (estimated coeff = 0.022, SE= 0.001).For quantitative covariates, BMI and age, the results
obtained from the estimated model were: BMI-estimated
coeff = 0.0001(SE = 0.00005) and age-estimated coeff =
8.494 (SE = 0.003).
Discussion
This study provides clear confirmation that WBC count
rises with smoking, even in a healthy, employed population.
The count was higher in smokers by 1000–1300 cells/ml
across a broad range of ages for both men and women and
across a broader span of ages for men. Spirometric markers
of lung function were also lower in healthy smokers.
The relation between smoking and WBC count has been
reported previously [4,12-15]. Zalokar and colleagues [4],
on studying more than 7000 men employed in public ad-
ministration in Paris, found that a higher percentage of
Table 6 White blood cell count (cells/ml) and FEV1% in smokers
Male smokers Female smokers
Age (years) FEV1 (% ) BMI≥30 25≤ BMI <30 BMI <25 BMI≥30 25≤ BMI <30 BMI <25
16–24 ≥80 7595(1824) 7072(1735) 6895(1746) 8121(1978) 7458(1849) 7024(1887)
≥50 <80 9102(2281) 7855(1992) 6649(1967) 10300(-) 8764(2128) 7128(1780)
<50 — 7400(-) 7430 (395) 5650(-) — 7517 (4931)
25–34 ≥80 7623(1873) 7136(1848) 6923(1852) 8014(1967) 7252(1887) 6821(1819)
≥50 <80 8124(1876) 7543(1889) 6988(2237 ) 7701(1810) 7447(1619) 7142(1959)
<50 9615(2211) 7096(1596) 7300(2937) 8367(1760) 8050(1906) 7538(1922)
35–44 ≥80 7595(1944) 7188(1954) 7083(2094) 7732(1999) 7138(1867) 6778(1876)
≥50 <80 8216(2208) * 7613(1925) 7768(2468) * 7819(1723) 6926(1780) 7284(2321)
<50 7965(1497) 7993(2102) 9589(3245) 9480(1584) 6250(540) 7772(2286)
45–54 ≥80 7386(1859) 7134(1955) 7265(2168) 7108(1800) 6747(1785) 6530(1798)
≥50 <80 8240(2161) * 7872(2090) * 8602(2419) * 8042(2080) 7696(1724) * 7682(1867) *
<50 7912(2120) 8269(2255) 8333(2508) 8258(1756) 7696(2236) 6831(1090)
55–64 ≥80 7141(1732) 6983(1815) 7087(1984) 6646(1671) 6305(1551) 6139(1616)
≥50 <80 8031(2150) * 7736(8042) * 7720(1853) * 6607(1505) 7462(2085) 6781(2393)
<50 7649(1779) 7704(1687) 8291(1937) 5863(1244) 6192(1922) 6598(1642)
Values are means (SD).
*Median test for white blood cell count in male and female smokers. Comparisons are between three levels of airway obstruction reflected by FEV1%. (P< 0.001)
BMI: Body mass index (kg/m2).
FEV1(%): Forced vital capacity expressed as a percentage respect to normal value.
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http://www.tobaccoinduceddiseases.com/content/10/1/7smokers had WBC counts over 6800 cells/ml. More re-
cently, Smith and colleagues [12] demonstrated higher
counts in a sample of 6902 male and 8405 female smokers.
Elevated WBC counts play a role in processes that lead to
cardiovascular diseases and increased risk of death. In one
recent cohort study, mortality was higher in relation to a
WBC count over 6000 cells/ml [13]. In an early prospective
cohort study in which subjects were followed for 6.5 years,
Friedman and colleagues [14,15] showed that smoking was
associated with higher rates of myocardial infarcts and that
WBC counts were much higher in smokers.
Age is also associated with WBC count. Although it was
recently claimed that this marker decreases with age [13],
we found that older male smokers had higher WBC counts,
while levels in nonsmokers remained stable (Table 3), a
finding that is consistent with a widely reported dose–re-
sponse effect of smoking [4,16-22]. The observation of a
lower WBC count in smokers who quit also points to the
relevance of dose on effect. Roethig and colleagues [23] re-
cently reported that WBC count decreased within the first
three days of abstinence and that lower counts were sus-
tained after a year of follow-up of former smokers. At five
years, WBC counts approximated those of nonsmokers. In
differential cell counts, elevated subpopulations of granulo-
cytes and lymphocytes have also been observed in smokers
[12,23-25]. However, it is important to note that BMI also
affects WBC count, with obesity creating a proinflamma-
tory state characterized by increases in C reactive protein
and interleukin 6 concentrations as well as in WBC count[26,27]. In our study, ANCOVA identified BMI as a covari-
ant of WBC count, as smokers in higher BMI strata were
found to have elevated counts regardless of sex or lung
function. Within age ranges, however, male smokers who
had developed airflow limitation had still higher counts.
BMI and smoking have an inverse relationship [28].
Recently, Kauffman et al. showed that this relationship is
moderated by sedentary conduct [29]. BMI was higher
in larger sedentary compared to lower sedentary smo-
kers. In our work, while BMI was statistically significant,
this difference was not clinically significant The health
benefit of being a nosmoker possibly outways by far the
extra risk that less than a 1 kg/m2 increase in BMI.
Finally, our study also demonstrated lower spirometric
variables (FEV1% and FEV1/FVC%) in smokers and that
WBC counts were more sharply elevated in smokers
with evident airflow limitation. This association between
the development of bronchial obstruction and the degree
of systemic inflammation reflected by total WBC count
is clinically significant and consistent with the findings
of Gan and colleagues [30,31]. These authors studied
more than 7000 adults (>40 years of age) during a na-
tional nutritional study that collected data on several
markers of inflammation, observing that counts and
concentrations were high in smokers and that elevation
was related to FEV1%. Such findings, like ours, indicate
that the effects of smoking clearly extend beyond the
well-known repercussions on the respiratory system to
include low-grade systemic inflammation, a known risk
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http://www.tobaccoinduceddiseases.com/content/10/1/7factor for health conditions that increase risk of mortal-
ity such as arterial sclerosis, heart failure, and reduced
cerebral blood flow. That we found that even the young
smokers in our study were affected underlines the im-
portance of initiating preventive measures as soon as an
individual acquires the smoking habit.
The study’s main limitation was the unavailability of
information about smoking duration and dose (packet-
years), which would have given us greater understanding
of the dose–response effect of smoking on WBC count.
On the other hand, the study’s strength resides in its
large sample size and an extensive age range.
In summary, this study in a healthy population undergo-
ing a routine workplace check-up provides direct evidence
of the proinflammatory effect of smoking, specifically ele-
vated WBC counts. The link between smoking and ele-
vated WBC count persisted even after stratification of the
sample for age, sex, and BMI, which were also independ-
ent predictors. Finally, in this healthy population we
observed a close tie between the development of airflow
limitation and smoking. Although this study has provided
clear evidence of a proinflammatory effect of smoking that
begins early in healthy smokers, the cross-sectional design
does not allow us to provide incidence rates that would in-
dicate when disease processes begin to develop.
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